HF specialists agree these drugs will be key tools in fighting the obesity-related HFpEF epidemic. Hurdles and questions ...
In the United Kingdom, the government is hoping weight loss drugs might improve public finances, eyeing their use to help ...
Medpage Today on MSN20h
Tirzepatide Officially Puts GLP-1 Meds on the Map for Obesity-Related Heart FailureCHICAGO -- A long-acting GIP/GLP-1 receptor agonist conferred significant clinical benefit for people with obesity and ...
(Reuters) -Shares in European vaccine makers fell on Friday after U.S. President-elect Donald Trump picked Robert F. Kennedy ...
Health stocks tumbled as vaccine sceptic RFK Jr. was named by President-elect Trump to head the Department of Health and ...
The 73rd annual Miss Universe pageant is taking place in Mexico on Saturday. More than 120 women from all over the world are ...
The UK medicines regulator approved Eli Lilly's Alzheimer's disease therapy Kisunla today, but the drug is too expensive to be funded by the NHS, according to cost-effectiveness watchdog NICE.
Dr. Mikki Sapkota, a neurologist, has joined Conemaugh Physician Group at Conemaugh East Hills Outpatient Center. Sapkota received a medical degree with distinction in 2016 from Kathmandu Medical ...
The GLORIOUS trial found that an intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) during heart surgeries ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback